Summary
Release of alpha-melanocyte-stimulating hormone (α-MSH) from slices of rat hypothalamus superfused with artificial cerebro-spinal fluid (ACSF) was quantified by radioimmunoassay. Addition of 10-6 M quinpirole, a D2-dopamine receptor agonist, to the superfusion medium caused a significant (P < 0.001) reduction in the amount of α-MSH released upon depolarisation with 50 mM potassium from 319 ±37% to 110 ±16% of basal release in normal ACSF (mean ±S.E.M.). Basal peptide release in the presence of quinpirole was unaffected. Sulpiride, a D2-dopamine receptor antagonist, at a concentration of 10-6 M, induced a significant (P < 0.05) increase of both basal and potassium-stimulated α-MSH release to 203 ±21% and 447 ±88% of basal release in normal ACSF respectively. The latter increases were abolished when sulpiride and quinpirole were added in combination. SK&F 38393-A and SCH 23390, a D1-dopamine agonist and antagonist respectively, had no significant effect on either basal or potassiumstimulated α-MSH release. It is proposed that endogenous dopamine exerts an inhibitory control on α-MSH release from the rat hypothalamus via D2-dopamine receptors and that in isolated hypothalamic slices there is a tonic inhibition of peptide release due to the activity of this system.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bugnon C, Bloch B, Lenys D, Gouget A, Felmann D (1979) Comparative study of the neuronal populations containing β-endorphin, corticotrophin and dopamine in the arcuate nucleus of the rat hypothalamus. Neurosci Lett 14: 43–48
Barnes S, Leighton GE, Davies JA (1988) A novel superfusion chamber for the measurement of endogenous glutamate release from cerebellar slices. J Neurosci Meth 23: 57–61
Dubé D, Lissitzky JC, Leclerc R, Pelletier G (1978) Localization of α-melanocyte-stimulating hormone in rat brain and pituitary. Endocrinology 102: 1283–1291
Eipper BA, Mains RE (1978) Analysis of the common precursor to corticotropin and endorphin. J Biol Chem 253: 5732–5744
Glowinski J, Iversen LL (1966) Regional studies of catecholamines in the rat brain-I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]DOPA in various regions of the brain. J Neurochem 13: 655–669
Healy MJR (1972) Statistical analysis of radioimmunoassay data. Biochem J 130: 207–210
Jacobowitz DM, O'Donohue TL (1978) α-melanocyte-stimulating hormone: immunohistochemical identification and mapping in neurons of the brain. Proc Natl Acad Sci USA 75: 6300–6304
Jégou S, Delbende C, Tranchand-Bunel D, Leroux P, Vaudry H (1987) α-melanocyte-stimulating hormone (α-MSH) release from perifused rat hypothalamic slices. Brain Res 413: 259–266
Kebabian JW, Agui T, van Oene JCM, Shi Gematsu K, Saavedra JM (1986) The D1 dopamine receptor: new perspectives. Trends Pharmacol Sci 7: 96–99
Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277: 93–96
Locatelli V, Petraglia F, Penalva A, Panerai AE (1983) Effect of dopaminergic drugs on hypothalamic and pituitary immunoreactive β-endorphin concentrations in the rat. Life Sci 33: 1711–1717
McKelvy JF, LeBlanc P, Laudres C, Perrie S, Grimm-Jorgersen Y, Kordon C (1976) The use of bacitracin as an inhibitor of the degradation of thyrotropin releasing factor and luteinizing hormone releasing factor. Biochem Biophys Res Commun 73: 507–515
Monnet F, Reubi J-C, Eberle A, Lichtensteiger W (1981) Diurnal variation in the release of alpha-MSH from rat hypothalamus and pituitary. Neuroendocrinology 33: 284–287
Nohtomi A, Itoh M, Yufu N (1984) Effects of sulpiride treatment on the levels of immunoreactive β-endorphin in rat hypothalamic nuclei. Brain Res 300: 152–156
O'Donohue TL, Charlton CG, Thoa NB, Helke CJ, Moody TW, Pert A, Williams A, Miller RL, Jacobowitz DM (1981) Release of alpha-melanocyte stimulating hormone into rat and human cerebrospinal fluid in vivo and from rat hypothalamus slices in vitro. Peptides 2: 93–100
O'Donohue TL, Miller RL, Jacobowitz DM (1979) Identification, characterization and stereotaxic mapping of intraneural αmelanocyte-stimulating hormone-like immunoreactive peptides in discrete regions of the rat brain. Brain Res 176: 101–123
Okuma Y, Osumi Y (1986) KCl-induced calcium-independent release of endogenous dopamine from rat brain slices. Brain Res 363: 47–52
Robertson GS, Robertson HA (1987) D1 and D2 dopamine agonist synergism: separate sites of action? Trends Pharmacol Sci 8: 295–299
Tagliamonte A, de Montis G, Olianas M, Virgin L, Corsini GU, Gessa GL (1975) Selective increase of brain dopamine synthesis by sulpiride. J Neurochem 26: 707–710
Tiligada E, Wilson JF (1988) Dopaminergic inhibition of alphamelanocyte-stimulating hormone release from superfused slices of the rat hypothalamus. Brain Res 457: 379–382
Vermes I, Tilders FJH, Stoof JC (1985) Dopamine inhibits the release of immunoreactive β-endorphin from rat hypothalamus in vitro. Brain Res 326: 41–46
Wilson JF (1979) Statistical evaluation of a radioimmunoassay for alpha-melanotropin. J Pharmacol Meth 2: 117–126
Wilson JF, Morgan MA (1979) A radioimmunoassay for alphamelanotropin in rat plasma. J Pharmacol Meth 2: 97–116
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tiligada, E., Wilson, J.F. D2-but not D1-dopamine receptors are involved in the inhibitory control of alpha-melanocyte-stimulating hormone release from the rat hypothalamus. Exp Brain Res 74, 645–648 (1989). https://doi.org/10.1007/BF00247368
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00247368